Página principalLGND • NASDAQ
add
Ligand Pharmaceuticals
$87.28
Fuera del horario comercial:(0.00%)0.00
$87.28
Cerrados: 10 may, 8:00:00 p.m. GMT-4 · USD · NASDAQ · Renuncia de responsabilidad
Cierre anterior
$86.12
Intervalo del día
$84.05 - $87.33
Intervalo anual
$49.24 - $94.57
Cap. bursátil
1567.87 M USD
Volumen prom.
168.73 k
Relación precio‑beneficio
16.68
Rendimiento por dividendos
-
Mercado primario
NASDAQ
Noticias
Finanzas
Estado de ingresos
Ingresos
Ingresos netos
| (USD) | dic 2023info | Cambio interanual |
|---|---|---|
Ingresos | 28.10 M | -44.22% |
Gastos de operación | 24.33 M | -38.67% |
Ingresos netos | 18.19 M | 204.02% |
Margen de utilidad neta | 64.72 | 286.51% |
Ganancias por acción | 1.38 | 1.47% |
EBITDA | 5.56 M | 162.05% |
Tasa impositiva vigente | -6.38% | — |
Balance general
Activos totales
Pasivos totales
| (USD) | dic 2023info | Cambio interanual |
|---|---|---|
Inversiones plazo/efectivo | 170.31 M | -19.62% |
Activos totales | 787.22 M | 3.22% |
Pasivos totales | 86.30 M | -47.75% |
Acciones totales | 700.91 M | — |
Acciones en circulación | 17.71 M | — |
Precio/valor contable | 2.16 | — |
Rendimiento de los activos | -1.08% | — |
Rendimiento del capital | -1.22% | — |
Flujo de efectivo
Variación neta en caja
| (USD) | dic 2023info | Cambio interanual |
|---|---|---|
Ingresos netos | 18.19 M | 204.02% |
Efectivo de operaciones | 8.06 M | -84.92% |
Efectivo de inversiones | -10.28 M | -41.19% |
Efectivo de financiación | 5.32 M | 200.32% |
Variación neta en caja | 3.10 M | -92.43% |
Flujo de efectivo libre | -40.12 M | -235.29% |
Acerca de
Ligand Pharmaceuticals is a biopharmaceutical company located in San Diego, California. Founded in 1987 as Progenix Inc., the company went public in 1992. Initially focused on developing its own drugs, a period of turbulence in the early 2000s culminated in its CEO being ejected by the shareholders and provoked a change in focus to the acquisition of existing drugs and forming partnerships to develop them further.
The company has been the subject of multiple regulatory investigations, negative shorts-seller reports and class action lawsuits amid allegations of securities fraud.
In 2018 its CEO was listed among the top five highest paid CEOs in San Diego. Wikipedia
Fecha de fundación
sept 1987
Sede principal
Sitio web
Cantidad de empleados
58
